PhotoSonix Medical is developing a treatment for dermal diseases generated by bacterial biofilm.

PhotoSonix Medical is developing a treatment for dermal diseases generated by bacterial biofilm, such as acne. Biofilms, which make treatment extremely difficult, shield bacteria from attack by both drugs and the immune system, often inducing a chronic inflammatory response. Photosonix’s product, CLENS™, will cut through biofilm by combining both ultrasound and violet light to kill underlying biofilm bacteria.

Industry: Health
Status: Active

Contact Information

http://photosonixmed.com/

Mark Evan Schafer

President & COO

Ph.D.

CSO

Tessie McNeely

Executive Chairman

Ph.D.

Adam Dakin